North Carolina sues Juul; J&J plans 10 drug launches by 2023; Novartis could settle kickback suit.
Bayer ordered to pay $2 billion in Roundup lawsuit; Scientists predict next cities to be hit with measles outbreak; AbbVie settles Humira patent lawsuit with Boehringer Ingelheim.
Teva, Mylan shares pulled down by anti-trust lawsuit; Insys hints it may file for Chapter 11; U.S. measles cases pass 800 mark.
Gilead to donate Truvada; Lilly migraine drug pulls ahead of rivals; Washington State ends personal, philosophical exemptions to vaccination.
Juul campaign draws criticism; Novartis buys dry-eye drug Xiidra; The five companies with the most at stake by putting list prices in TV ads.
MM&M’s Transforming Healthcare conference; Trump administration moves forward with drug-price-in-advertising requirement; Walmart raises minimum age to buy tobacco.
More than 75% say kids should be vaccinated even over a parent’s objection; CBD drug Epidiolex beats expectations; Allergan CEO plans “decisive action” in company turnaround.
CDC said New York is driving most new measles cases; FDA approves drug for rare heart condition; Lundbeck buys CBD-focused pharma company.
Weight Watchers misses on Q1 revenue; Pharma lobbying spend reaches 10-year high; First U.S. CRISPR clinical trial seeks approval.
Jury finds Insys execs guilty in opioid kickback trial; Attorneys argue federal opioid data should be public; More than half of Americans struggle because of medical bills.
Humana CEO won’t back “Medicare for all”; FDA rejects Heron non-opioid painkiller; GSK predicts shingles vaccine will top $1.3b in sales this year.
See MM&M’s Top 40 Healthcare Transformers and Top 10 Innovation Catalysts; Voting begins in the #ConvinceMeToVax contest; Rich Levy joins Klick.